Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer

Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Recently, clinical trials have focused on novel antiangiogenic agents in combination with chemotherapy or alone in women with primary and recurrent ovarian cancer. Antiangiogenic agents include monoclonal antibodies, tyrosine-k...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidson, Brittany A, Secord, Angeles Alvarez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958497/
https://www.ncbi.nlm.nih.gov/pubmed/24648773
http://dx.doi.org/10.2147/IJWH.S49781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958497/
https://www.ncbi.nlm.nih.gov/pubmed/24648773
http://dx.doi.org/10.2147/IJWH.S49781

Ejemplares similares